Blue Owl Capital Holdings LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$546.2M2026 Q3+ $1.4M options (notional, not included)
Positions79
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.77.4%

Blue Owl Capital Holdings LP reported 79 positions worth $546.2M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: SPCX (25.4%).

10 / 79 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 SPCXSpace Exploration Technologies$139.3M25.43%923,218——-8.9%
▸ 2 AKTSAktis Oncology$65.1M11.89%3,343,827——-17.0%
▸ 3 LTGOLatigo Biotherapeutics$60.1M10.97%3,596,780——-22.6%
▸ 4 LRMRLarimar Therapeutics$31.7M5.79%9,923,904——-6.1%
▸ 5 ETRAElectra Therapeutics$29.4M5.36%2,611,143——-26.1%
▸ 6 NCDLNuveen Churchill Direct$24.1M4.40%2,143,626——+4.9%
▸ 7 CGEMCullinan Therapeutics$21.5M3.92%1,399,899——-38.1%
▸ 8 OBDCBlue Owl Capital$21.5M3.92%2,045,070——+3.2%
▸ 9 OBXObsidian Therapeutics$20.4M3.72%1,482,767———
▸ 10 SGMTSagimet Biosciences$11.1M2.03%1,125,544——+3.4%

Pro Feature

The remaining 69 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Blue Owl Capital Holdings LP hold as of Q3 2026?

Blue Owl Capital Holdings LP reported 79 positions worth $546.2M in its Q3 2026 13F filing. Largest positions: SPCX (25.4%), AKTS (11.9%), LTGO (11.0%), LRMR (5.8%) and ETRA (5.4%).

What did Blue Owl Capital Holdings LP buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Blue Owl Capital Holdings LP sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.